# China NMPA Drug Inspection - Guangdong Bidi Pharmaceutical Co., Ltd. - Acyclovir tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangdong-bidi-pharmaceutical-co-ltd/63146c42-933d-49ef-8610-0b9e5c03aead/
Source feed: China

> China NMPA drug inspection for Guangdong Bidi Pharmaceutical Co., Ltd. published November 16, 2021. Drug: Acyclovir tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 3, 2021)
- Company Name: Guangdong Bidi Pharmaceutical Co., Ltd.
- Publication Date: 2021-11-16
- Drug Name: Acyclovir tablets
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/guangdong-bidi-pharmaceutical-co-ltd/9a65ac49-13c6-41f6-958d-5f65389cd848/